VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,170,884 | -10.6% | 43,503 | 0.0% | 0.43% | -6.6% |
| Q2 2023 | $1,309,875 | -4.7% | 43,503 | +2.4% | 0.46% | -10.0% |
| Q1 2023 | $1,374,972 | +18.7% | 42,503 | +5.2% | 0.51% | +17.0% |
| Q4 2022 | $1,157,950 | +15.9% | 40,403 | -2.4% | 0.44% | +17.9% |
| Q3 2022 | $999,000 | -16.3% | 41,403 | -5.0% | 0.37% | -8.7% |
| Q2 2022 | $1,194,000 | -30.5% | 43,603 | -2.7% | 0.40% | -13.9% |
| Q1 2022 | $1,718,000 | +28.3% | 44,803 | +7.2% | 0.47% | +40.4% |
| Q4 2021 | $1,339,000 | +7.1% | 41,803 | -1.4% | 0.33% | -1.5% |
| Q3 2021 | $1,250,000 | -13.4% | 42,403 | – | 0.34% | -13.5% |
| Q2 2021 | $1,443,000 | +7.0% | 0 | -100.0% | 0.39% | -0.8% |
| Q1 2021 | $1,348,000 | -9.7% | 41,463 | 0.0% | 0.40% | -14.3% |
| Q4 2020 | $1,493,000 | -8.1% | 41,463 | -0.1% | 0.46% | -17.7% |
| Q3 2020 | $1,625,000 | +7.9% | 41,500 | +1.1% | 0.56% | -3.8% |
| Q2 2020 | $1,506,000 | +61.2% | 41,050 | +1.2% | 0.58% | +26.2% |
| Q1 2020 | $934,000 | -22.7% | 40,550 | -1.7% | 0.46% | +2.7% |
| Q4 2019 | $1,208,000 | +8.8% | 41,250 | -0.7% | 0.45% | +0.9% |
| Q3 2019 | $1,110,000 | +12.7% | 41,550 | +7.8% | 0.44% | +6.0% |
| Q2 2019 | $985,000 | +14.0% | 38,550 | 0.0% | 0.42% | +10.5% |
| Q1 2019 | $864,000 | +15.2% | 38,550 | +8.4% | 0.38% | +12.1% |
| Q4 2018 | $750,000 | -12.8% | 35,550 | -23.5% | 0.34% | +3.7% |
| Q3 2018 | $860,000 | -20.1% | 46,450 | -3.7% | 0.33% | -27.3% |
| Q2 2018 | $1,076,000 | -1.4% | 48,250 | -2.8% | 0.45% | -4.1% |
| Q1 2018 | $1,091,000 | -5.5% | 49,650 | 0.0% | 0.47% | -3.5% |
| Q4 2017 | $1,154,000 | -10.0% | 49,650 | -11.1% | 0.49% | -16.1% |
| Q3 2017 | $1,282,000 | +4.0% | 55,850 | 0.0% | 0.58% | -2.4% |
| Q2 2017 | $1,233,000 | +2.5% | 55,850 | +5.9% | 0.59% | -4.0% |
| Q1 2017 | $1,203,000 | +29.4% | 52,750 | +18.7% | 0.62% | +12.2% |
| Q4 2016 | $930,000 | -36.8% | 44,450 | -20.1% | 0.55% | -36.2% |
| Q3 2016 | $1,471,000 | +7.4% | 55,650 | +12.5% | 0.86% | +4.0% |
| Q2 2016 | $1,370,000 | – | 49,450 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |